BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ArthroSurface Receives CE Mark Approval for Uni Knee Resurfacing System


6/24/2008 6:41:16 AM

FRANKLIN, Mass., June 23 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has received the CE Mark approval for its UniCAP(TM) Unicondylar resurfacing system. With this approval, the company is poised to move into the fast growing European market of partial knee replacements. "We have taken our clinical experiences from the company's HemiCAP(R) focal knee resurfacing product in Europe, in part, to create a larger sized Unicondylar knee system that is joint preserving while having the fit of a device similar to an off-the-shelf custom implant", said Steve Ek, COO.

Many patients with knee arthritis have damage on only one side of their knee. If detected early, damage to the cartilage surface is often localized and the meniscus, the main shock absorbing structure of the knee joint, may still be functional. "What makes the UniCAP(TM) system unique is that it is the only Unicondylar knee system on the market that allows for the preservation of the soft tissues about the knee, including the meniscus, and preserves the healthy tissues and bone in the knee. In addition, the ability to perform the procedure as an arthroscopically assisted surgery will benefit the patient, especially for those that continue an active lifestyle", commented Anthony Miniaci, M.D. of the Cleveland Clinic.

The company believes that its product lines address a gap in existing treatments, specifically between biological options and joint replacement. The company maintains that biological treatments, such as grafting and cell regeneration, may be viable options for those that are young; alternatively total joint replacement surgery may be effective for those that are much older or less active. It is the Millennium Patient(TM), a typical middle-aged and active patient as termed by the company, that may not be suited for either of these options. The UniCAP(TM) system may now provide an option for this previously unaddressed market.

"With the development of the different Arthrosurface systems over the past five years, we have effectively become the new joint preservation company for the orthopaedic surgeon", summarized Steve Ek.

CONTACT: Anthony C. Moretti, CFO of Arthrosurface, Inc., +1-508-520-3003

Web site: http://arthrosurface.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES